Gritstone bio, Inc. (GRTS)
NASDAQ: GRTS · IEX Real-Time Price · USD
0.772
+0.033 (4.47%)
At close: Apr 16, 2024, 4:00 PM
0.777
+0.005 (0.66%)
After-hours: Apr 16, 2024, 4:08 PM EDT

Gritstone bio Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20232022202120202019201820172016
Net Income
-138.49-119.69-75.08-105.31-94.43-64.79-41.45-18.75
Depreciation & Amortization
21.6515.6914.414.1611.133.961.970.82
Share-Based Compensation
11.6212.5610.557.115.331.130.6
Other Operating Activities
-16.43-24.51-0.55-5.05-719.673.382.04
Operating Cash Flow
-121.65-115.95-50.68-89.1-85.01-38.16-34.97-15.29
Capital Expenditures
-4.57-5.87-5.7-3.52-16.17-5.66-11.49-6.98
Change in Investments
106.91-7.09-112.8569.4632.01-53.44-21.76-25.14
Investing Cash Flow
102.34-12.96-118.5565.9515.84-59.1-33.25-32.13
Share Issuance / Repurchase
8.9365.51117.21135.9175.292.590.010.23
Debt Issued / Paid
17.1318.48-8.45-0.1-0.81-3.0800
Other Financing Activities
-0.95-0.89---20.9495.835.71
Financing Cash Flow
25.1283.1108.76135.874.4110.4495.8135.95
Net Cash Flow
5.81-45.81-60.47112.655.2313.1827.59-11.47
Free Cash Flow
-126.22-121.82-56.38-92.62-101.18-43.83-46.46-22.28
Free Cash Flow Margin
-772.27%-610.77%-116.93%-2294.20%-2318.08%-3692.08%--
Free Cash Flow Per Share
-1.09-1.34-0.71-2.45-3.02-4.91-23.24-13.32
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).